Benzodiazepines
Sedative-hypnotic agents for procedural sedation, anxiolysis, and critical care applications.
Product Overview
Our benzodiazepine portfolio includes midazolam and lorazepam, essential medications for procedural sedation, ICU sedation, and management of anxiety and seizures. All products are manufactured under DEA-licensed conditions.
| Product | Concentration | Fill Volume | Container | Schedule | BUD |
|---|---|---|---|---|---|
| Midazolam 1 mg/mL | 1 mg/mL | 2 mL, 5 mL | SDV | C-IV | 24 months |
| Lorazepam 2 mg/mL | 2 mg/mL | 1 mL | SDV | C-IV | 12 months |
Midazolam Applications
- • Procedural sedation
- • Preoperative anxiolysis
- • ICU sedation (short-term)
- • Status epilepticus
- • Conscious sedation protocols
Lorazepam Applications
- • Status epilepticus (first-line)
- • Anxiety disorders
- • Alcohol withdrawal
- • Preoperative sedation
- • Chemotherapy-induced nausea
Related Articles
April 25, 2026
Medivant Healthcare is proud to announce the launch of Andrela™
Medivant Healthcare is proud to announce the launch of Andrela™ the first 503B cGMP compounded microdose testosterone cypionate in prefilled syringes. Testosterone therapy is not one-size-fits-all. Individualized dosing at lower therapeutic levels demands a delivery format capable of matching clinical intent exactly — and until now, that format simply didn't exist.
Read More
April 25, 2026
The future of testosterone therapy; Meet Andrenyx™.
Medivant Healthcare is proud to announce the launch of Andrenyx™ (compounded testosterone cypionate) a single-dose prefilled syringe engineered for precision, sterility, and real-world clinical usability.
Read More
January 10, 2026
Medivant Healthcare Partners with Angels for Change to Address Drug Shortages
Medivant Healthcare announces its partnership with Angels for Change and the upcoming launch of Lorazepam injectable vials to help address critical drug shortages.
Read MoreRequest Product Information
Contact our team for specifications, pricing, and availability.